INBRX-109,Carboplatin,Cisplatin,Pemetrexed,5-fluorouracil,Irinotecan,Temozolomide
inhibrx
['sarcoma']
did you see present today #asco23? want more? hot off the press preclinical characterization &amp; phase 1 trial results of inbrx-109, a third-generation, recombinant, humanized, death receptor 5 agonist antibody, in chondrosarcoma 
Executive Editor of Clinical Cancer Research @CCR_AACR @AACR. @BrownUPathoGP @NUAlumni Cat gal & home chef. Go Cats! Opinions are my own.